Insider Activity of See Tai Sandi
According to the SEC Form 4 filings, See Tai Sandi, being in a position of
- Chief Development Officer at Lexeo Therapeutics, Inc. Common Stock,оver the last 12 months, has bought 0 shares, and sold 386 shares for $3,578,over all time since 2025-02-19, has bought 0 shares, and sold 6509 shares for $47,704.
Biography of See Tai Sandi
No biography is available at this moment.